ARKGARK Genomic Revolution ETF
ARKG Options Overview
IV is elevated with bullish flow. No clear edge detected.
REWARDS
RISK ANALYSIS
ARKG Gamma Walls
Value
Is IV priced right?
Measures whether options are cheap, fair, or rich relative to historical and peer
IV Rank 72.9% — elevated vs history
IV/HV 0.99x — IV ≤ HV
Sector percentile 84% — above sector median
Front/Back 0.91x — contango
Put/Call IV 1.16x — elevated
ATM IV 49.5% — normal range
Effective IV 66.8% (ATM 49.5% + spread 8.7% + bias) — fair
Total drag 13.24% (spread 8.66% + slippage 4.58%) — high friction
Vega efficiency 7.05 (vega 6.102 / spread 8.66%) — efficient
Sentiment
Bullish or bearish?
Analyzes
Conviction-weighted: -19% (bearish) — Raw: -24%
|OI skew| 9.3% — balanced
Vol skew +57.4%, OI skew +9.3% — aligned
0-DTE 28%, far-OTM 15%, avg DTE 30
OI change +0.0% (5d) — stable
ITM: -27%, ATM: -63%, OTM: +16% — strong bearish (ITM/ATM aligned)
Sector P/C percentile 14% — very bullish vs sector
Activity
Unusual activity?
Detects volume surges,
Volume 0.4x avg — normal
Vol/OI 2.4% — normal turnover
1 day(s) elevated — may be one-day event
OI change -20.9% (5d) — unwinding
Sector activity percentile 48% — neutral vs sector
Large trade volume 39% — institutional presence
Aggressive execution 32% — patient
Conviction -19 (bearish) — mixed
Liquidity
Can I trade efficiently?
Evaluates
Spread 8.7% — wide
OI 209,843 — deep
Volume 4,940/day — adequate
$0.43 to cross — cheap
0 liquid strikes — limited options
Sector spread percentile 88% — much wider than sector
Depth 426.0 contracts (bid:250.4 ask:175.6) — adequate
Avg slippage 4.58% — poor
Timing
Is now a good time?
Considers earnings proximity,
Slope -8.6% — contango
IV percentile 73% — seller opportunity
IV kink -2.7pts — no clear event
θ/ν ratio 141.26 — favors income trades
4 liquid expirations — flexible
safe window: No earnings detected
Spread ratio 1.00x — stable
Flow -19% @ 60% consistency — unclear
Score 69 (ITM 20% + inst 39%) — HIGH institutional
Directional Strategy Fit
For educational purposes only. Not investment advice.